Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 356

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018

Haddad, Robert I., Nasr, Christian, Bischoff, Lindsay, Busaidy, Naifa Lamki, Byrd, David, Callender, Glenda, Dickson, Paxton, Duh, Quan-Yang, Ehya, Hormoz, Goldner, Whitney, Haymart, Megan, Hoh, Carl, Hunt, Jason P., Iagaru, Andrei, Kandeel, Fouad, Kopp, Peter, Lamonica, Dominick M., McIver, Bryan, Raeburn, Christopher D., Ridge, John A., Ringel, Matthew D., Scheri, Randall P., Shah, Jatin P., Sippel, Rebecca, Smallridge, Robert C., Sturgeon, Cord, Wang, Thomas N., Wirth, Lori J., Wong, Richard J., Johnson-Chilla, Alyse, Hoffmann, Karin G., Gurski, Lisa A.·2018·Journal of the National Comprehensive Cancer Network

Abstract

The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E–mutated anaplastic thyroid carcinoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2018.0089

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 356

Metadata

Authors
Haddad, R. I., Nasr, C., Bischoff, L., Busaidy, N. L., Byrd, D., Callender, G., Dickson, P., Duh, Q.-Y., Ehya, H., Goldner, W., Haymart, M., Hoh, C., Hunt, J. P., Iagaru, A., Kandeel, F., Kopp, P., Lamonica, D. M., McIver, B., Raeburn, C. D., Ridge, J. A., Ringel, M. D., Scheri, R. P., Shah, J. P., Sippel, R., Smallridge, R. C., Sturgeon, C., Wang, T. N., Wirth, L. J., Wong, R. J., Johnson-Chilla, A., Hoffmann, K. G., & Gurski, L. A.
Venue
Journal of the National Comprehensive Cancer Network
Published
2018-12
Volume
16
Issue
12
Pages
1429-1440
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
OpenAlex
W2904679600
Cited by
356
References
45
FWCI
23.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. https://app.cochat.ai/papers/10.6004/jnccn.2018.0089
The paper
Haddad, R. I., Nasr, C., Bischoff, L., Busaidy, N. L., Byrd, D., Callender, G., Dickson, P., Duh, Q.-Y., Ehya, H., Goldner, W., Haymart, M., Hoh, C., Hunt, J. P., Iagaru, A., Kandeel, F., Kopp, P., Lamonica, D. M., McIver, B., Raeburn, C. D., . . . Gurski, L. A. (2018). NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2018.0089

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.